Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.598 USD | +4.18% | -3.66% | -19.80% |
15/05 | Traws Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
07/05 | Traws Pharma Completes First Cohort Dosed in Phase 1 Trial for COVID Therapy | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.80% | 1.26Cr | |
+48.64% | 5.67TCr | |
-6.44% | 3.94TCr | |
+38.14% | 3.9TCr | |
+14.28% | 2.67TCr | |
-11.17% | 2.69TCr | |
-21.40% | 1.9TCr | |
+25.64% | 1.23TCr | |
+0.96% | 1.23TCr | |
+27.04% | 1.2TCr |
- Stock Market
- Equities
- TRAW Stock
- News Traws Pharma, Inc.
- Onconova Therapeutics Discloses Plan for Phase 1/2a Cancer Trial